Figure 1From: Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trialFlow diagram for the induction phase of the trial protocol. nAMD: neovascular Age Related Macular Degeneration. PIS: patient information sheet. VA: visual acuity.Back to article page